Fluphenazine Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 1 mg, 2.5 mg, 5 mg, 10 mg
Reference Brands: Prolixin®(US); Modecate®(EU)
Category:
Antipsychotropic Drugs
Fluphenazine is a typical antipsychotic that primarily works by blocking dopamine D2 receptors in the brain, helping to reduce positive symptoms of psychosis such as hallucinations, delusions, and disorganized thinking. Fluphenazine tablets are used in the management of schizophrenia and other chronic psychotic disorders, especially for long-term maintenance therapy.
Fluphenazine Tablets is available in Oral Tablets
and strengths such as 1 mg, 2.5 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluphenazine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluphenazine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluphenazine tablets are FDA-approved in the United States for the treatment of schizophrenia and other chronic psychotic disorders. In the European Union, they are available in select countries via national authorizations. Regulatory requirements include GMP-compliant manufacturing, clinical safety data addressing extrapyramidal symptoms, and adherence to FDA and EMA psychiatric labeling standards. U.S. filings must comply with NDA or ANDA guidelines, including bioequivalence data. EU submissions may require bridging studies and updated pharmacovigilance plans. To explore dossier-ready Fluphenazine tablets, alternate forms, and verified suppliers, visit Pharmatradz.com — your global B2B platform for pharmaceutical sourcing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing